参考文献/References:
[1] 刘争强,章文春.气本质研究之“四辩”[J].中华中医药杂志,2024,39(4):1618-1622.
[2] 梁茂新.论现代概念语境下的中医学异化[J].中华中医药杂志,2024,39(4):1683-1691.
[3] WANG K,LI G Z,YANG Z,et al.Compound Chinese medicine(F1)improves spleen deficiency diarrhea by protecting the intestinal mucosa and regulating the intestinal flora[J].Frontiers in Microbiology,2024,14:1292082.
[4] YAN S Y.Thoughts on the construction of flagship hospitals of integrated traditional Chinese and Western medicine in China[J].Journal of Integrative Medicine,2025,23(1):12-14.
[5] DOS SANTOS FERREIRA R R,ORTEGA F.Sobre o reducionismo na pesquisa do trauma [On reductionism in trauma research][J].Cadernos de Saúde Pública,2025,41:e00226524.
[6] MÉNDEZ-VIDAL C,BRAVO-GIL N,PÉREZ-FLORIDO J,et al.A genomic strategy for precision medicine in rare diseases:integrating customized algorithms into clinical practice[J].Journal of Translational Medicine,2025,23(1):86.
[7] PUN J,CHOR W.Use of questioning between traditional Chinese medicine practitioners and patients to realize TCM philosophy:holism,five elements and Yin-Yang in the context of doctor-patient communication[J].Health Communication,2022,37(2):163-176.
[8] WANG Y Y,LIU M X,JAFARI M,et al.A critical assessment of traditional Chinese medicine databases as a source for drug discovery[J].Frontiers in Pharmacology,2024,15:1303693.
[9] JIASHUO W U,ZHANG F Q,ZHUANGZHUANG L I,et al.Integration strategy of network pharmacology in traditional Chinese medicine:a narrative review[J].Journal of Traditional Chinese Medicine,2022,42(3):479-486.
[10] WANG Y L,SHI X M,LI L,et al.The impact of artificial intelligence on traditional Chinese medicine[J].The American Journal of Chinese Medicine,2021,49(6):1297-1314.
[11] GUO R,ZENG D,ZHAO Q,et al.How are different traditional Chinese medicine modalities deployed by clinical practitioners in China? Findings from a national survey[J].Journal of Integrative Medicine,2025,23(1):36-45.
[12] 世界中医药学会联合会,呼吸疾病中医药防治省部共建协同创新中心,河南中医药大学,等.中医证候诊断标准研制指南[J].中国循证医学杂志,2023,23(9):993-998.
[13] 李建生,冯贞贞,谢洋,等.病证结合模式下中医证候疗效评价量表研制的实践与策略[J].中国全科医学,2022,25(20):2513-2519.
[14] 田夏,柴倩云,张丽娟,等.不同医生辨证与针刺处方差异的临床研究[J].中医杂志,2017,58(6):498-501.
[15] BENSOUSSAN A,TALLEY N J,HING M,et al.Treatment of irritable bowel syndrome with Chinese herbal medicine:a randomized controlled trial[J].JAMA,1998,280(18):1585-1589.
[16] INGBER D E.Human organs-on-chips for disease modelling,drug development and personalized medicine[J].Nature Reviews Genetics,2022,23(8):467-491.
[17] VUNJAK-NOVAKOVIC G,RONALDSON-BOUCHARD K,RADISIC M.Organs-on-a-chip models for biological research[J].Cell,2021,184(18):4597-4611.
[18] SHROFF T,AINA K,MAASS C,et al.Studying metabolism with multi-organ chips:new tools for disease modelling,pharmacokinetics and pharmacodynamics[J].Open Biology,2022,12(3):210333.
[19] HABANJAR O,DIAB-ASSAF M,CALDEFIE-CHEZET F,et al.3D cell culture systems:tumor application,advantages,and disadvantages[J].International Journal of Molecular Sciences,2021,22(22):12200.
[20] LIU X X,SU Q P,ZHANG X Y,et al.Recent advances of organ-on-a-chip in cancer modeling research[J].Biosensors,2022,12(11):1045.
[21] PULLEN K M,FINETHY R,KO S B,et al.Cross-species transcriptomics translation reveals a role for the unfolded protein response in Mycobacterium tuberculosis infection[J].NPJ Systems Biology and Applications,2025,11(1):19.
[22] ÖZTÜRK A,ERSAN Ö.Are the lives of animals well-spent in laboratory science research?A study of orthopaedic animal studies in Turkey[J].Clinical Orthopaedics and Related Research,2020,478(9):1965-1970.
[23] FRÜHWEIN H,PAUL N W.“Lost in translation?” Animal research in the era of precision medicine[J].Journal of Translational Medicine,2025,23(1):152.
[24] SAJIN D,MOONSHI S S,CHA H T,et al.Multi-organ-on-a-chip:the gut and inflammatory diseases[J].ACS Biomaterials Science & Engineering,2025,11(9):5330-5342.
[25] HUANG S Y,HUANG F Y,YANG L W,et al.Shentao Ruangan granule ameliorates cholestatic liver disease via a microbiota-dependent gut-liver axis[J].Journal of Ethnopharmacology,2026,359:121069.
[26] PALMA-FLOREZ S,LAGUNAS A,MIR M.Neurovascular unit on a chip:the relevance and maturity as an advanced in vitro model[J].Neural Regeneration Research,2024,19(6):1165-1166.
[27] CECEN B,KARAVASILI C,NAZIR M,et al.Multi-organs-on-chips for testing small-molecule drugs:challenges and perspectives[J].Pharmaceutics,2021,13(10):1657.
[28] BANAEIYAN A A,THEOBALD J,PAUKTYTE J,et al.Design and fabrication of a scalable liver-lobule-on-a-chip microphysiological platform[J].Biofabrication,2017,9(1):015014.
[29] DU Y,LI N,YANG H,et al.Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip[J].Lab on a Chip,2017,17(5):782-794.
[30] DU Y,KHANDEKAR G,LLEWELLYN J,et al.A bile duct-on-a-chip with organ-level functions[J].Hepatology,2020,71(4):1350-1363.
[31] WANG Y Q,WANG P,QIN J H.Microfluidic organs-on-a-chip for modeling human infectious diseases[J].Accounts of Chemical Research,2021,54(18):3550-3562.
[32] HUANG Q H,YANG T H,SONG Y P,et al.A three-dimensional(3D)liver-kidney on a chip with a biomimicking circulating system for drug safety evaluation[J].Lab on a Chip,2024,24(6):1715-1726.
[33] KURNIAWAN D A,LEO S,INAMATSU M,et al.Gut-liver microphysiological systems revealed potential crosstalk mechanism modulating drug metabolism[J].PNAS Nexus,2024,3(2):pgae070.
[34] RONALDSON-BOUCHARD K,TELES D,YEAGER K,et al.A multi-organ chip with matured tissue niches linked by vascular flow[J].Nature Biomedical Engineering,2022,6(4):351-371.
[35] WANG P,JIN L,ZHANG M,et al.Blood-brain barrier injury and neuroinflammation induced by SARS-CoV-2 in a lung-brain microphysiological system[J].Nature Biomedical Engineering,2024,8(8):1053-1068.
[36] ECKSTRUM K,STRIZ A,FERGUSON M,et al.Evaluation of the utility of the Beta Human Liver Emulation System(BHLES)for CFSAN's regulatory toxicology program[J].Food and Chemical Toxicology,2022,161:112828.
[37] PIRES DE MELLO C P,CARMONA-MORAN C,MCALEER C W,et al.Microphysiological heart-liver body-on-a-chip system with a skin mimic for evaluating topical drug delivery[J].Lab on a Chip,2020,20(4):749-759.
[38] 李兆钰,丁书文,马度芳,等.基于心系疾病热毒学说探讨中医药抗炎治疗动脉粥样硬化[J].中华中医药杂志,2021,36(7):3916-3920.
[39] 王栋,于雪,黄凯,等.清热解毒中药调节炎症反应对心血管疾病异病同治的意义[J].中国中药杂志,2022,47(20):5418-5423.
[40] GAO Z,DU Z Y,HOU Y,et al.A microfluidic coculture model for mapping signaling perturbations and precise drug screening against macrophage-mediated dynamic myocardial injury[J].Acta Pharmaceutica Sinica:B,2024,14(12):5393-5406.
[41] CHEN P,ZHANG J,WANG C,et al.The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine[J].Phytomedicine,2022,100:154044.
[42] 孙雪,何建成,杨帅.何建成教授分期治疗帕金森病痴呆的经验[J].中华中医药学刊,2023,41(5):127-130.
[43] TRAPECAR M,WOGRAM E,SVOBODA D,et al.Human physiomimetic model integrating microphysiological systems of the gut,liver,and brain for studies of neurodegenerative diseases[J].Science Advances,2021,7(5):eabd1707.
[44] NGUYEN V V T,YE S C,GKOUZIOTI V,et al.A human kidney and liver organoid-based multi-organ-on-a-chip model to study the therapeutic effects and biodistribution of mesenchymal stromal cell-derived extracellular vesicles[J].Journal of Extracellular Vesicles,2022,11(11):12280.
[45] SHI Y W,HE X L,WANG H,et al.Construction of a novel blood brain barrier-glioma microfluidic chip model:applications in the evaluation of permeability and anti-glioma activity of traditional Chinese medicine components[J].Talanta,2023,253:123971.
[46] FAN F F,XU N,SUN Y C,et al.Uncovering the metabolic mechanism of salidroside alleviating microglial hypoxia inflammation based on microfluidic chip-mass spectrometry[J].Journal of Proteome Research,2022,21(4):921-929.
[47] ZHANG H Y,HUANG H M,SONG H,et al.Serum metabolomics reveals the intervention mechanism and compatible regularity of Chaihu Shu Gan San on chronic unpredictable mild stress-induced depression rat model[J].Journal of Pharmacy and Pharmacology,2020,72(8):1133-1143.
[48] 马骏,曼琼,邓毅,等.代谢组学在中药七情配伍中的应用研究进展[J].中草药,2020,51(1):276-280.
[49] 张凯,任献青,霍桢毅,等.基于气味配伍理论辨治儿童血尿[J].中国中医基础医学杂志,2020,26(7):884-886.
[50] 王一婷,冯全生,刘文平,等.《脾胃论》“苦甘”配伍思想发微[J].中华中医药杂志,2022,37(8):4610-4613.
[51] LV S,WANG Q,ZHANG X L,et al.Mechanisms of multi-omics and network pharmacology to explain traditional Chinese medicine for vascular cognitive impairment:a narrative review[J].Phytomedicine,2024,123:155231.
[52] LU Z H,YUAN Y,HAN Q,et al.Lab-on-a-chip:an advanced technology for the modernization of traditional Chinese medicine[J].Chinese Medicine,2024,19(1):80.
[53] MILANI N,PARROTT N,ORTIZ FRANYUTI D,et al.Application of a gut-liver-on-a-chip device and mechanistic modelling to the quantitative in vitro pharmacokinetic study of mycophenolate mofetil[J].Lab on a Chip,2022,22(15):2853-2868.
[54] CHEN Y Y,LU Y T,WANG Y D,et al.Xiaoyaosan improves depression-like behaviours in mice with post-stroke depression by modulating gut microbiota and microbial metabolism and regulating P2X7R/NLRP3 inflammasome[J].Phytomedicine,2025,145:157078.
(收稿日期:2025-11-18)